Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DMS

Market Cap 32.91M 37.75M 30.48M 28.54M 53.52M 3.56B 53.84M 362M 140M 1.75B 142M 139M 6.09B P/E 2026 *
42.3x
P/E 2027 * 12.7x
Enterprise Value 48.31M 55.41M 44.75M 41.89M 78.56M 5.23B 79.03M 531M 206M 2.57B 208M 204M 8.94B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 0.62x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 18/07/2022
Director of Finance/CFO - 01/01/2022
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 56 -
Chairman 53 18/07/2022
Director/Board Member 52 16/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 37.75M
-5.99%-9.24%-19.45%-24.47% 12.54B
-0.26%+7.72%+93.53%+22.87% 5.27B
-1.04%-3.45%-36.22%-65.08% 1.21B
+1.69%-0.95%-32.67%-43.30% 1.19B
+1.22%-1.50%+58.31%+92.56% 1.18B
-0.53%-3.60%-37.73% - 949M
-5.27%-1.71%+213.40%+194.59% 704M
+1.69%-8.07% - - 330M
-0.74%-0.55%-57.45%+200.00% 247M
Average -0.92%-2.23%+22.71%+53.88% 2.62B
Weighted average by Cap. -3.30%-3.88%+14.39%-0.94%

Financials

2026 *2027 *
Net sales 56.8M 65.15M 52.61M 49.25M 92.36M 6.15B 92.92M 624M 242M 3.03B 245M 239M 10.51B 65.9M 75.58M 61.03M 57.14M 107M 7.13B 108M 724M 281M 3.51B 284M 278M 12.19B
Net income 800K 918K 741K 694K 1.3M 86.58M 1.31M 8.79M 3.41M 42.61M 3.44M 3.37M 148M 2.6M 2.98M 2.41M 2.25M 4.23M 281M 4.25M 28.57M 11.07M 138M 11.19M 10.95M 481M
Net Debt 15.4M 17.66M 14.26M 13.35M 25.04M 1.67B 25.19M 169M 65.58M 820M 66.3M 64.88M 2.85B 8M 9.18M 7.41M 6.94M 13.01M 866M 13.09M 87.9M 34.07M 426M 34.44M 33.7M 1.48B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!